GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Binimetinib (Mektovi), adult oral tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Mektovi - labeled renal guidance

Product / population
Binimetinib (Mektovi), adult oral tablets
Renal method
Indexed GFR/eGFR, mL/min/1.73 m2
Source revision
DailyMed SPL version 12, effective 2025-03-20; posted Mar 24, 2025
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Mektovi - product and source limitations

Separately, renal impairment with elevated CPK can require withholding treatment. Check the adverse-reaction table before continuing therapy.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Mektovi - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Binimetinib (Mektovi), adult oral tablets

Renal method: Indexed GFR/eGFR, mL/min/1.73 m2
Source date: DailyMed SPL version 12, effective 2025-03-20; posted Mar 24, 2025
Retrieved: 2026-11-07

Pharmacokinetic observation only. A drug-exposure observation is not itself a dose recommendation.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 12.3 and 2, dosage modifications for adverse reactions

In severe renal impairment (eGFR <=29 mL/min/1.73 m2), systemic exposure did not change to a clinically important degree in the cited study. Separately, renal impairment with elevated CPK can require withholding treatment. Check the adverse-reaction table before continuing therapy.

RDM73-mektovi-official-1 · Source locator: Renal guidance: 12.3 and 2, dosage modifications for adverse reactions

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c3408ac-d401-4925-8a03-26591afbc240
Retrieved
2026-11-07
Renal-function method
Indexed GFR/eGFR, mL/min/1.73 m2
Source date/version
DailyMed SPL version 12, effective 2025-03-20; posted Mar 24, 2025
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
817a804b40cef3e9bc424e7747ef2f81f46d68ed401bb67b9979b3b72bf2e562

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=binimetinib-mektovi&s1=RDM73-mektovi-official&h1=c626637e48a572ff757ee7b41e3dac34254012b996c590262fa87598d0d2e7bb

Top